Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Extended release formulations of erythromycin derivatives

US Patent 6551616 · Granted Apr 22, 2003

Estimated economic value: $136,966,000

Assignee

Inventors

View full patent text on Google Patents →